MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by Boston Scientific Corporation
IMPERIAL 12-Month Full Cohort and Long Lesion Sub-Study Results
Sustained drug-release in the SFA drives superior results.
By William A. Gray, MD, Additional commentary by Prof. Stefan Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA, FSIR